Cyclo Therapeutics, Inc. 8-K Report: Stock Insights & Updates (March 2023)

Here are the key insights extracted from the provided financial report section:

1. Entity Information:

• Company Name: Cyclo Therapeutics, Inc.
• CIK Number: 0000922247
• SEC File Number: 000-25466
• IRS Employer Identification Number (EIN): 59-3029743
• Address: 6714 NW 16th Street, Suite B, Gainesville, FL 32653
• Phone Number: 386-418-8060

2. Stock Information:

• Common Stock: The par value of the common stock is $0.0001 per share.
• Ticker Symbol: CYTH (Common Stock), CYTHW (Warrants to Purchase Common Stock)
• Exchange: NASDAQ

3. Reporting Period:

• Report Date: March 20, 2023
• The report covers a single day (March 20, 2023).

4. Stock Categories and Custom Members:

• The report includes classifications for different stock types:
• • Common Stock Par Value: $0.0001 per share.
  • Warrants to Purchase Common Stock.

5. XML and XBRL Context:

• The report utilizes XML and XBRL (eXtensible Business Reporting Language) for structuring financial information.
• Relevant namespaces include US GAAP and custom dimensions for stock classification.

6. Document Type:

• This filing appears to be an 8-K form, which is used for reporting unscheduled material events or corporate changes.

Summary:

Cyclo Therapeutics, Inc. reported on March 20, 2023, concerning its common stock and warrants. The common stock has a par value of $0.0001 and is traded under the ticker symbol CYTH on NASDAQ, while warrants are under CYTHW. The report is structured using XBRL for better data management and reporting compliance.